Modulation of complement membrane attack by local C7 synthesis.
作者信息
Würzner R
机构信息
Institute of Hygiene & Social Medicine, Leopold Franzens University, Innsbruck, Austria.
出版信息
Clin Exp Immunol. 2000 Jul;121(1):8-10. doi: 10.1046/j.1365-2249.2000.01263.x.
Abstract
摘要
相似文献
1
Modulation of complement membrane attack by local C7 synthesis.通过局部C7合成对补体膜攻击的调节。
Clin Exp Immunol. 2000 Jul;121(1):8-10. doi: 10.1046/j.1365-2249.2000.01263.x.
2
Cytotoxic action and other metabolic consequences of terminal complement proteins.末端补体蛋白的细胞毒性作用及其他代谢后果。
Prog Allergy. 1988;40:44-81.
3
Lack of linkage between gene(s) controlling the synthesis of the seventh component of complement and the HLA region on chromosome No. 6 in man.
Hum Genet. 1976 Oct 28;34(2):137-42. doi: 10.1007/BF00278881.
4
The role of the complement system in innate immunity.补体系统在固有免疫中的作用。
Immunol Res. 2005;33(2):103-12. doi: 10.1385/IR:33:2:103.
5
6
Monitoring Surface Reactions by Combined Western Blot-ELISA Analysis.通过蛋白质免疫印迹-酶联免疫吸附测定联合分析监测表面反应
Methods Mol Biol. 2019;1834:75-83. doi: 10.1007/978-1-4939-8669-9_5.
7
The membrane attack pathway of complement.补体的膜攻击途径。
Year Immunol. 1989;6:229-44.
8
Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
J Immunol. 1995 May 1;154(9):4734-40.
9
引用本文的文献
1
Biomarkers of the Complement System in Cancer.癌症中补体系统的生物标志物
Medeni Med J. 2025 Mar 28;40(1):1-11. doi: 10.4274/MMJ.galenos.2025.34783.
2
Exploring the causal effect of complement and IgA nephropathy-a Mendelian randomization study.探索补体与IgA肾病的因果关系——一项孟德尔随机化研究
Ren Fail. 2024 Dec;46(2):2436632. doi: 10.1080/0886022X.2024.2436632. Epub 2024 Dec 3.
3
Complement C7 and clusterin form a complex in circulation.补体 C7 与簇集素在循环中形成复合物。
Front Immunol. 2024 Jan 25;15:1330095. doi: 10.3389/fimmu.2024.1330095. eCollection 2024.
4
Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth.雄激素调节的基质补体成分 7（C7）抑制前列腺癌生长。
Oncogene. 2023 Aug;42(32):2428-2438. doi: 10.1038/s41388-023-02759-7. Epub 2023 Jul 3.
5
Hsa_circ_0072309 is a prognostic biomarker and is correlated with immune infiltration in gastric cancer.Hsa_circ_0072309是一种预后生物标志物，与胃癌中的免疫浸润相关。
Heliyon. 2023 Feb 4;9(2):e13191. doi: 10.1016/j.heliyon.2023.e13191. eCollection 2023 Feb.
6
Interacting Effects of Sea Louse () Infection and Formalin-Killed on Atlantic Salmon Skin Transcriptome.海虱感染与福尔马林灭活对大西洋鲑鱼皮转录组的互作效应。
Front Immunol. 2022 Mar 24;13:804987. doi: 10.3389/fimmu.2022.804987. eCollection 2022.
7
Functional genetic variants in complement component 7 confer susceptibility to gastric cancer.补体成分7中的功能性基因变异赋予胃癌易感性。
PeerJ. 2022 Jan 18;10:e12816. doi: 10.7717/peerj.12816. eCollection 2022.
8
Plasma complement C7 as a target in non-small cell lung cancer patients to implement 3P medicine strategies.血浆补体C7作为非小细胞肺癌患者实施3P医学策略的靶点。
EPMA J. 2021 Nov 25;12(4):629-645. doi: 10.1007/s13167-021-00266-x. eCollection 2021 Dec.
9
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.补体系统的治疗靶向：从罕见病到流行病。
Pharmacol Rev. 2021 Apr;73(2):792-827. doi: 10.1124/pharmrev.120.000072.
10
A Personal Tribute to a Highly Inspiring Mentor, Professor Sir Peter J. Lachmann, 1931-2020.向极具启发性的导师彼得·J·拉赫曼爵士教授致敬，1931-2020 年。
Viruses. 2021 Jan 29;13(2):206. doi: 10.3390/v13020206.
本文引用的文献
1
The Fluid-phase SC5b-9 Terminal Complement Complex Binds to the GPIIb/IIIa Complex of Thrombin-stimulated Human Blood Platelets Inhibiting Platelet Aggregation.液相 SC5b-9 末端补体复合物与凝血酶刺激的人血小板上的 GPIIb/IIIa 复合物结合，抑制血小板聚集。
Platelets. 1995;6(3):160-8. doi: 10.3109/09537109509013269.
2
The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system.内皮是补体系统第七成分的肝外合成部位。
Clin Exp Immunol. 2000 Jul;121(1):69-76. doi: 10.1046/j.1365-2249.2000.01238.x.
3
Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry.病原体通过部分借助分子模拟来避免被补体识别或清除，从而实现免疫逃逸。
Mol Immunol. 1999 Mar-Apr;36(4-5):249-60. doi: 10.1016/s0161-5890(99)00049-8.
4
5
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.细胞溶解无活性的末端补体复合物激活内皮细胞，使其表达黏附分子和组织因子促凝活性。
J Exp Med. 1997 May 5;185(9):1619-27. doi: 10.1084/jem.185.9.1619.
6
Extrahepatic complement biosynthesis: where, when and why?肝外补体生物合成：何处、何时以及为何？
Clin Exp Immunol. 1997 Jan;107(1):1-7. doi: 10.1046/j.1365-2249.1997.d01-890.x.
7
Expression of complement in the brain: role in health and disease.补体在大脑中的表达：在健康与疾病中的作用。
Immunol Today. 1996 Oct;17(10):461-6. doi: 10.1016/0167-5699(96)20028-f.
8
Interaction between complement proteins C5b-7 and erythrocyte membrane sialic acid.补体蛋白C5b-7与红细胞膜唾液酸之间的相互作用。
J Exp Med. 1996 Oct 1;184(4):1225-32. doi: 10.1084/jem.184.4.1225.
9
Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans.人类骨髓和肝脏对循环中C7水平的器官特异性贡献。
Eur J Immunol. 1996 Sep;26(9):2108-12. doi: 10.1002/eji.1830260922.
10
How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion.伴有慢性复发性细菌感染的部分C7缺乏如何模拟完全C7缺乏：输血后宿主C7水平的暂时恢复。
Immunology. 1996 Jul;88(3):407-11. doi: 10.1046/j.1365-2567.1996.d01-663.x.
Zotero 插件